Dr. Abdul Ali Abdellatif, MD

Dr. Abdellatif practices at US Renal Care Gulfgate Kidney Center in Webster, Texas.

Dr. Abdellatif's NPI, 1164560595, was assigned on February 1, 2007. Dr. Abdellatif graduated from Universidad Autonoma de Guadalajara in 2001. Dr. Abdellatif's Texas license number on file is M5007.

Dr. Abdellatif's primary practice is US Renal Care Gulfgate Kidney Center, at 500 N Kobayashi Rd, Webster, TX 77598 in Harris County. The practice phone is (346) 772-0517.

Dr. Abdellatif's primary practice is US Renal Care Gulfgate Kidney Center in Webster, Texas. Dr. Abdellatif is also affiliated with HCA Houston Healthcare Clear Lake. The medical group on file is CLS Health. Dmand AI also links Dr. Abdellatif to 4 more hospitals, 5 dialysis centers, 4 group practices and clinics, 3 medical groups, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdellatif practices, 16 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Abdellatif's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Abdellatif is board certified in nephrology by the American Board of Internal Medicine. Dr. Abdellatif has a license on file in Texas.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, gout and parathyroid gland disorder among the conditions Dr. Abdellatif treats.

CMS data shows 25,416 Medicare services from Dr. Abdellatif across 15 procedure codes in 2024, for 583 Medicare patients. Medicare paid $583,451 for them.

CMS counts 583 Medicare patients who saw Dr. Abdellatif in 2024. The largest group is 65 to 74, with 236 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdellatif's median patient age at 71, with 45% women.

In 2024, Dr. Abdellatif wrote 6,415 Medicare Part D claims for 639 patients. 85% of them were for generic drugs. CMS names the drug for 5,851 of them, across 128 drugs with 11 or more claims each, at $1,626,908 in total drug cost. In 2023, CMS named 5,649 claims across 122 drugs.

Dr. Abdellatif accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdellatif as offering telehealth.

Dmand AI links 37 papers to Dr. Abdellatif, published from 2009 to 2025. 2010 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Gout and Gout Suppressants. Dr. Abdellatif has published most often in Saudi J Kidney Dis Transpl. Dr. Abdellatif's most frequent co-authors are Brad A. Marder, MD, Waqar M. Haque and Omar Pacha, MD.

Dmand AI links Dr. Abdellatif to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2 and Obesity. Open Payments lists research payments to Dr. Abdellatif that name 1 trial.

CMS Open Payments shows 3,472 general payments to Dr. Abdellatif from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Horizon Pharma plc paid the most, $524,987. It also lists 3 research payments totaling $127,123 from 2023 to 2024, naming 1 clinical trial.

Dmand AI lists 11 awards for Dr. Abdellatif, most recently CMS Stage 1 EHR in 2013.

Dr. Abdellatif graduated from Universidad Autonoma de Guadalajara in 2001. Dr. Abdellatif is a member of ASN.

Dr. Abdellatif is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.